Intergroup study of fluorouracil plus levamisole as adjuvant therapy for stage II/Dukes' B2 colon cancer.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Journal of Clinical Oncology

• Publication date

  1995-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1200/JCO.1995.13.12.2936PMID 8523058
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fluorouracil plus Levamisole as Effective Adjuvant Therapy after Resection of Stage III Colon Carcinoma: A Final Report

  1995cited by this paper
• Late mortality and levamisole adjuvant therapy in colorectal cancer.

  1994cited by this paper
• Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. German Cancer Aid 17-1A Study Group.

  1994cited by this paper
• Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma

  1994cited by this paper
• Allelic loss of chromosome 18q and prognosis in colorectal cancer.

  1994cited by this paper
• The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03.

  1993cited by this paper
• Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project.

  1992cited by this paper
• DNA ploidy and cell kinetic measurements as predictors of recurrence and survival in stages B2 and C colorectal adenocarcinoma

  1991cited by this paper
• Surgical considerations in patients with cancer of the colon and rectum.

  1991cited by this paper
• Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma.

  1990cited by this paper
• Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic.

  1989cited by this paper
• Regression Models and Life-Tables

  1972cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper

• Robotic Resection of Colonic Medullary Carcinoma: A Case Report

  2025cites this paper
• Survival paradox between stage IIB/C and stage IIIA colon cancer: is it time to revise the American Joint Committee on Cancer TNM system?

  2024cites this paper
• Principles of risk assessment in colon cancer: immunity is key

  2024cites this paper
• Underutilization or appropriate care? Assessing adjuvant chemotherapy use and survival in 3 heterogenous subpopulations with stage II/III colorectal cancer within a large integrated health system

  2023cites this paper
• Impact of adjuvant chemotherapy on long-term overall survival in patients with high-risk stage II colon cancer: a nationwide cohort study

  2023cites this paper
• Stage II Medullary Carcinoma of the Colon: A Surgery Case Report

  2023cites this paper
• Adjuvant chemotherapy is associated with improved overall survival in select patients with Stage II colon cancer: A National Cancer Database analysis

  2022cites this paper
• Prognostic Value of Mesorectal Lymph Node Micrometastases in ypN0 Rectal Cancer After Chemoradiation.

  2022cites this paper
• Is High-Grade Tumor Budding an Independent Prognostic Factor in Stage II Colon Cancer?

  2022cites this paper
• Combination Chemotherapy of Multidrug-resistant Early-stage Colon Cancer: Determining Optimal Dose Schedules by High-performance Computer Simulation

  2022cites this paper
• Perioperative Chemotherapy for Liver Metastasis of Colorectal Cancer: Lessons Learned and Future Perspectives

  2022cites this paper
• Chronotherapy of Early Colon Cancer: Advantage of Morning Dose Schedules

  2022cites this paper
• Oncotype DX testing does not affect clinical practice in stage IIa colon cancer

  2022cites this paper
• Adjuvant treatment of colon cancer with microsatellite instability - the state of the art.

  2021cites this paper
• Racial Disparities in the Management of Locoregional Colorectal Cancer.

  2021cites this paper
• Novel imidazo[2,1‐b]thiazole‐based anticancer agents as potential focal adhesion kinase inhibitors: Synthesis, in silico and in vitro evaluation

  2021cites this paper
• Colon Cancer

  2021cites this paper
• Interpretable survival prediction for colorectal cancer using deep learning

  2020cites this paper
• Synergistic therapy with tangeretin and 5-fluorouracil accelerates the ROS/JNK mediated apoptotic pathway in human colorectal cancer cell.

  2020cites this paper
• Novel Genetic and Epigenetic Biomarkers of Prognostic and Predictive Significance in Stage II/III Colorectal Cancer.

  2020cites this paper
• Development of a Risk Score and Nomogram to Predict Individual Benefit Attained from the Addition of Adjuvant Chemotherapy in the Treatment of Stage II Colon Cancer

  2020cites this paper
• Lessons learnt from scoring adjuvant colon cancer trials and meta-analyses using the ESMO-Magnitude of Clinical Benefit Scale V.1.1

  2020cites this paper
• Adjuvant Chemotherapy for Stage II Colon Cancer

  2020cites this paper
• Real-world evidence on adjuvant chemotherapy in older adults with stage II/III colon cancer

  2020cites this paper
• Patterns of Care for Stage II-III Rectosigmoid Cancers in the United States, 2004-2015

  2020cites this paper
• Chemotherapy for elderly colorectal cancer patients at a tertiary hospital in South Africa

  2020cites this paper
• Evaluation of prognosis and treatment response in colorectal cancer with focus on biomarkers

  2020cites this paper
• Association of Bevacizumab Plus Oxaliplatin-Based Chemotherapy With Disease-Free Survival and Overall Survival in Patients With Stage II Colon Cancer

  2020cites this paper
• Incorporating competing risk theory into evaluations of changes in cancer survival: making the most of cause of death and routinely linked sociodemographic data

  2020cites this paper
• Prevention of Colon Cancer Recurrence From Minimal Residual Disease: Computer Optimized Dose Schedules of Intermittent Apoptotic Adjuvant Therapy.

  2020cites this paper
• Challenges of improving treatment outcomes for colorectal and anal cancers in Japan: the Colorectal Cancer Study Group (CCSG) of the Japan Clinical Oncology Group (JCOG).

  2020cites this paper
• Indication for and Effect of Adjuvant Chemotherapy for Stage IIa (T3N0M0) Colon Cancer

  2019cites this paper
• Development of a novel prediction model for recurrent stage II colon cancer

  2019cites this paper
• Microsatellite Instability and Adjuvant Chemotherapy in Stage II Colon Cancer

  2019cites this paper
• Effectiveness in the Absence of Efficacy: Cautionary Tales From Real-World Evidence.

  2019cites this paper
• Adjuvant therapy for stages II and III colon cancer: risk stratification, treatment duration, and future directions.

  2019cites this paper
• Duration of Adjuvant Chemotherapy in Colon Cancer: Current Standards and New Updates

  2019cites this paper
• Optimal duration of adjuvant therapy for stage III colon cancer.

  2019cites this paper
• Colorectal Cancer Biomarkers in the Era of Personalized Medicine

  2019cites this paper
• Adjuvant Therapy for Colorectal Cancer

  2019cites this paper
• LncRNAs as Regulators of Autophagy and Drug Resistance in Colorectal Cancer

  2019cites this paper
• Adjuvant chemotherapy in resected colon cancer: When, how and how long?

  2019cites this paper
• Adjuvant therapy in renal cell carcinoma: does higher risk for recurrence improve the chance for success?

  2018cites this paper
• Treatment of Elderly Patients with Colorectal Cancer

  2018cites this paper
• An investigation into the relationship between the postoperative systemic inflammatory response, complications, and oncologic outcomes following surgery for colorectal cancer

  2018cites this paper
• Differences in the outcomes of adjuvant chemotherapy for colon cancer prescribed by physicians in different disciplines: a population-based study in Taiwan

  2018cites this paper
• Emerging Systemic Therapies for Colorectal Cancer

  2018cites this paper
• The effect of levamisole in the treatment of recalcitrant recurrent erythema multiforme major: An observational study.

  2018cites this paper
• Stage II Colon Cancer: Towards an Individualized Approach

  2017cites this paper
• Molecular analysis of sentinel lymph node in colon carcinomas by one-step nucleic acid amplification (OSNA) reduces time to adjuvant chemotherapy interval.

  2017cites this paper
• MicroRNA analysis of colorectal cancer using fecal and tissue samples

  2017cites this paper
• Perioperatieve behandelingen en radicale cystectomie voor blaaskanker. Een trendanalyse over 10.338 patiënten in Nederland

  2017cites this paper
• Adjuvant Chemotherapy for Stage II Colon Cancer: A Clinical Dilemma.

  2017cites this paper
• Role of adjuvant chemotherapy in locally advanced rectal cancer with ypT0-3N0 after preoperative chemoradiation therapy and surgery

  2017cites this paper
• S3-Leitlinie – Kolorektales Karzinom

  2017cites this paper
• Number of Lymph Nodes in Primary Nodal Basin and a "Second Look" Protocol as Quality Indicators for Optimal Nodal Staging of Colon Cancer.

  2017cites this paper
• Farmacogenómica en el cáncer colorrectal

  2017cites this paper
• Utilization and impact of adjuvant chemotherapy among patients with resected stage II colon cancer: a multi-institutional analysis.

  2017cites this paper
• Sentinel Lymph Node and Occult Tumor Cells in Colon Cancer; the Good, the Bad, and the Ugly

  2017cites this paper
• The effect and clinical efficacy of lienal polypeptide injection combined with FOLFOX chemotherapy regimen in colon cancer patients

  2016cites this paper
• Association Between Results of a Gene Expression Signature Assay and Recurrence-Free Interval in Patients With Stage II Colon Cancer in Cancer and Leukemia Group B 9581 (Alliance).

  2016cites this paper
• Role of patient-reported symptoms and functioning in the care of patients with metastatic colorectal cancer

  2016cites this paper
• A Study of Thymidylate Synthase Expression as a Biomarker for Resectable Colon Cancer: Alliance (Cancer and Leukemia Group B) 9581 and 89803

  2016cites this paper
• Should the Benefit of Adjuvant Chemotherapy in Colon Cancer Be Re-Evaluated?

  2016cites this paper
• High expression of miR-181c as a predictive marker of recurrence in stage II colorectal cancer

  2016cites this paper
• Smaller tumor size is associated with poor survival in stage II colon cancer: An analysis of 7,719 patients in the SEER database.

  2016cites this paper
• Hospital Variability in Use of Adjuvant Chemotherapy for Patients with Stage 2 and 3 Colon Cancer

  2016cites this paper
• Adjuvant Therapy Trials.

  2016cites this paper
• Nutzung von Krebsregisterdaten zur Messung der Qualität in der klinischen Onkologie und für Versorgungsforschung

  2016influential citation
• Perioperative treatment and radical cystectomy for bladder cancer--a population based trend analysis of 10,338 patients in the Netherlands.

  2016cites this paper
• Multiple localized metachronous recurrences in a patient of colon cancer and therapeutic controversies in stage II colon cancer.

  2016cites this paper
• Poor survival in stage IIB/C (T4N0) compared to stage IIIA (T1-2 N1, T1N2a) colon cancer persists even after adjusting for adequate lymph nodes retrieved and receipt of adjuvant chemotherapy

  2016cites this paper
• Evolving concepts in staging and treatment of colorectal cancer

  2015cites this paper
• Defective Mismatch Repair Status was not Associated with DFS and OS in Stage II Colon Cancer Treated with Adjuvant Chemotherapy

  2015cites this paper
• High Risk Stage 2 and Stage 3 Colon Cancer, Predictors of Recurrence and Effect of Adjuvant Therapy in a Nonselected Population

  2015cites this paper
• Hospital academic status and value of care for nonmetastatic colon cancer.

  2015cites this paper
• Colorectal Cancer in Young Adults

  2015cites this paper
• Lebensqualität nach (neo-)adjuvanter Radiochemotherapie des Rektumkarzinoms

  2015cites this paper
• The use of gene expression profiling in the personalization of colorectal cancer treatment

  2015cites this paper
• The iKnife: real time Intra-operative tissue diagnostics using rapid evaporative ionisation mass spectrometry

  2015cites this paper
• Validation of a quantitative 12-multigene expression assay (Oncotype DX® Colon Cancer Assay) in Korean patients with stage II colon cancer: implication of ethnic differences contributing to differences in gene expression

  2015cites this paper
• Initial safety report on the tolerability of modified FOLFOX6 as adjuvant therapy in patients with curatively resected stage II or III colon cancer (JFMC41-1001-C2: JOIN trial)

  2015cites this paper
• Updates in Adjuvant Therapy

  2015cites this paper
• Stage II Colon Cancer : To Treat or Not to Treat ?

  2014cites this paper
• The role of adjuvant chemotherapy in stage II colorectal cancer patients

  2014cites this paper
• The lymph node ratio optimises staging in patients with node positive colon cancer with implications for adjuvant chemotherapy

  2014cites this paper
• MTHFR-1298 A>C (rs1801131) is a predictor of survival in two cohorts of stage II/III colorectal cancer patients treated with adjuvant fluoropyrimidine chemotherapy with or without oxaliplatin

  2014cites this paper
• Sentinel Lymph Node Detection in Colorectal Cancer – First Experience

  2014cites this paper
• The Number of Risk Factors Determines the Outcome Of Stage II Colorectal Cancer Patients.

  2014cites this paper
• Cancer colorectal : compte rendu anatomopathologique type en 2014

  2014cites this paper
• Dilemma of stage II colon cancer and decision making for adjuvant chemotherapy.

  2014cites this paper
• Identification of high-risk factors as indicators for adjuvant therapy in stage II colon cancer patients treated at a single institution

  2013cites this paper
• [S3-guideline colorectal cancer version 1.0].

  2013cites this paper
• S3-Leitlinie Kolorektales Karzinom

  2013cites this paper
• Facteurs pronostiques des cancers colorectaux localisés

  2013cites this paper
• Adjuvant Chemotherapy for Senior Patients After Resection of Colon Cancer

  2013cites this paper
• Evaluation of the efficacy of adjuvant chemotherapy in patients with high-risk stage II colon cancer.

  2013cites this paper
• Association between adherence to National Comprehensive Cancer Network treatment guidelines and improved survival in patients with colon cancer

  2013cites this paper
• Small vessel vasculitis associated with cocaine use.

  2013cites this paper
• New challenges for comparative effectiveness in oncology: choice of primary end points for randomized clinical trials.

  2013cites this paper